0001104659-15-012640.txt : 20150220 0001104659-15-012640.hdr.sgml : 20150220 20150220164638 ACCESSION NUMBER: 0001104659-15-012640 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150207 FILED AS OF DATE: 20150220 DATE AS OF CHANGE: 20150220 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000890465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 870439579 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 BUSINESS PHONE: (908) 450-5300 MAIL ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BESHAR LUKE M CENTRAL INDEX KEY: 0001192128 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23272 FILM NUMBER: 15636295 MAIL ADDRESS: STREET 1: 550 HILLS DRIVE STREET 2: 3RD FLOOR CITY: BEDMINSTER STATE: NJ ZIP: 07921 4 1 a4.xml 4 X0306 4 2015-02-07 0 0000890465 NPS PHARMACEUTICALS INC NPSP 0001192128 BESHAR LUKE M 550 HILLS DRIVE BEDMINSTER NJ 07921 0 1 0 0 EVP & CFO Common Stock 2015-02-07 4 J 0 8967 A 62780 D Common Stock 2015-02-07 4 F 0 3148 45.85 D 59632 D Common Stock 2015-02-12 4 M 0 3832 A 63464 D Common Stock 2015-02-12 4 F 0 1427 45.85 D 62037 D Common Stock 2015-02-13 4 M 0 10531 A 72568 D Common Stock 2015-02-13 4 F 0 4789 45.88 D 67779 D Common Stock 2015-02-17 4 M 0 3594 8.25 A 71373 D Common Stock 2015-02-17 4 M 0 2969 8.21 A 74342 D Common Stock 2015-02-17 4 M 0 859 38.27 A 75201 D Restricted Stock Units 2015-02-12 4 A 0 10905 0 A Common Stock 10905 10905 D Restricted Stock Units 2015-02-12 4 M 0 3832 0 D Common Stock 3832 7665 D Restricted Stock Units 2015-02-13 4 M 0 10531 0 D Common Stock 10531 10531 D Employee Stock Option (right to buy) 8.25 2015-02-17 4 M 0 3594 8.25 D 2021-02-17 Common Stock 3594 3594 D Employee Stock Option (right to buy) 8.21 2015-02-17 4 M 0 2969 8.21 D 2022-02-07 Common Stock 2969 14844 D Employee Stock Option (right to buy) 38.27 2015-02-17 4 M 0 859 38.27 D 2024-02-12 Common Stock 859 30615 D Shares acquired upon vesting of Restricted Stock Units granted to the Reporting Person on February 7, 2012 and reported on a Form 4 filed on February 9, 2012. The Reporting Person reported all Restricted Stock Units granted to the Reporting Person on February 7, 2012 in Table I of the Form 4 filed on February 9, 2012. As such, no adjustment to the Reporting Person's beneficial ownership needs to be made to reflect this vesting event. Shares were withheld from the Reporting Person, in an exempt transaction under Rule 16b-3, solely to satisfy tax obligations arising from the vesting of the Restricted Stock Units described in this Form 4. Each vested Restricted Stock Unit is the economic equivalent of one share of common stock of NPS Pharmaceuticals, Inc. (the "Issuer"). The vested Restricted Stock Units were settled for shares of the Issuer's common stock. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. Restricted Stock Units will vest as follows: (i) one third will vest on the first anniversary of date of grant, (ii) one third on the second anniversary of date of grant, and (iii) one third on the third anniversary of date of grant. Vested shares will be delivered to the Reporting Person as soon as administratively practicable following the vesting of the Restricted Stock Units. On February 12, 2014, the Restricted Stock Units were granted with (i) one third vesting on the first anniversary of the date of grant, (ii) one third vesting on the second anniversary of the date of grant and (iii) the remaining vesting on the third anniversary of the date of grant. On February 13, 2013, the Restricted Stock Units were granted with (i) one third vesting on the first anniversary of the date of grant, (ii) one third vesting on the second anniversary of the date of grant and (iii) the remaining vesting on the third anniversary of the date of grant. On February 17, 2011, the Reporting Person received a grant of 57,500 stock options under the Issuer's 1998 Stock Option Plan. The options become exercisable based on the following vesting schedule: 25% on the first anniversary of the grant and 6.25% every three months thereafter. On February 7, 2012, the Reporting Person received a grant of 47,500 stock options under the Issuer's 2005 Omnibus Incentive Plan. The options become exercisable based on the following vesting schedule: 25% on the first anniversary of the grant and 6.25% every three months thereafter. On February 12, 2014, the Reporting Person received a grant of 31,474 stock options under the Issuer's 2005 Omnibus Incentive Plan. The options become exercisable based on the following vesting schedule: 25% on the first anniversary of the grant and 6.25% every three months thereafter. /s/ Luke M. Beshar, by Jill Thompson as attorney-in-fact 2015-02-19